Periodic monitoring of copper and zinc levels is reasonable for extended use protocols, as the copper-zinc balance can shift with prolonged copper supplementation through any delivery mechanism
References Lau DCW, et al
Do not ever seek or attempt to filter or reuse doubtful solutions
Why it was included in the FDA ban Research on DSIP in humans is still lacking, per the FDA
HHS has announced that GHK-Cu is expected to return to Category 1, which would restore compounding access for injectable formulations. BPC-157 On 23 July 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulks List, in opposition to the FDA staff review, which had recommended against listing
The regulatory framework isnt designed to chase down thousands of small international shipments stamped for lab use